Due to the increased awareness efforts done by the government and people, the demand for goods and services in the healthcare business will continue to rise in the future.
In recent years, the global healthcare sector has experienced tremendous expansion. According to a new data bridge research named Women’s Health Market, “the worldwide women’s health market size was $35.02 billion in 2019 and is anticipated to reach $41.05 billion by 2027, demonstrating a CAGR of 3.2 percent between 2019 and 2030.”
It is obvious from the increase in the number of infrastructure facilities installed throughout various areas, as well as the explosion of companies catering to women’s health that have emerged or are in the pipeline. Topical treatments and pharmaceuticals, clinics, hospitals, and businesses dedicated to women’s healthcare, and edible enhanced dietary supplements, personal and intimate hygiene goods make up the majority of the offerings of the women’s healthcare industry.
There are several variables contributing to this rise, but one of the most important elements influencing the expansion of the women’s health industry is an increase in knowledge about health and well-being among women. Specifically, in India which there was a certain extent of lack of consideration or neglect towards women’s health due to restricted talks or taboos covering the topics, and unwillingness on the part of women in seeking a diagnosis with the treatment for their illnesses, a stark difference has resulted in a stark difference, making an increase in awareness the primary driver of growth.
Defining women’s health
The bodies of men and women are designed differently from conception.
According to the Institute of Medicine, “every cell has a sex,” and sex variations affect all tissues, organs, and body processes.
These distinctions have an impact on illness prevention, diagnosis, and therapy. Better outcomes in women’s health have cascade advantages for groups such as children and the elderly since women are typically caregivers. In other words, women’s health makes a big contribution to stronger, better societies.
Women’s health is considerably broader than reproduction. Our definition is broad in scope. When we think of women’s health, we think about both female-specific illnesses, whether they are related to women’s reproduction or another aspect of women’s biology, and general health issues that may impact women differently or disproportionately.
Market Analysis and Size of Women Health
- Procedures, drugs, and surgical aids used to address the many illnesses affecting this demographic collectively are referred to as “women’s health.” These diseases span a range of medical areas, including urology, nutrition, cancer, reproduction, menopause, and others. Enhancing women’s general health and improving illness management are the two main objectives of women’s health. The efforts of several governments to increase public awareness of women’s health are intensifying. Some organizations, such as the World Health Organization (WHO) and the US Food and Drug Administration (FDA), are introducing new safety initiatives to improve women’s health.
- The women’s health market, which was valued at USD 34.45 billion in 2021, is predicted by Data Bridge Market Research to increase at a Rate of 5.35% from 2022 to 2029, reaching USD 52.27 billion. The market report created by the Data Bridge Market Research team includes in-depth expert opinion, patient epidemiological studies, pipeline assessment, pricing analysis, and regulatory framework in addition to industry insights like market price, growth rate, target markets, geographical reach, market players, and market scenario.
Women’s healthcare market key players
Amgen (US) is a market leader in the women’s healthcare sector. The company’s sales and marketing efforts are heavily concentrated in the United States and Europe. The firm sells Prolia and Xgeva to treat osteoporosis in postmenopausal women. These pharmaceuticals have increased in value and volume by double digits year on year, and they account for the lion’s share of the market. Amgen’s EVENITY is also in phase 3 development for the treatment of osteoporosis in postmenopausal women. It is being worked on in partnership with UCB (Belgium). The company’s strong brand awareness and emphasis on product innovation have helped it maintain its market position.
Conclusion – women health
The women’s health sector has continuous issues; yet, these challenges also give entrepreneurs and company owners several chances to expand and develop creative solutions. Because of the increased awareness initiatives done by the government and people, the demand for goods and services in the women’s healthcare business will continue to rise in the future. untapped potential of the women’s healthcare sector has been disregarded for far too long, particularly in a developing country that is a popular destination for medical tourism, due to a lack of resource development and significant efforts in research and development. The bottom line should focus upon raising awareness and developing an environment that reaches every woman, regardless of barriers.
Certain products used in women’s healthcare have raised concerns in the minds of the younger generation. These develop as a result of the negative effects, such as nausea, headaches, spotting, and so on, produced by oral contraceptives, which account for around 34.2 percent of women’s healthcare offers and are an essential component of women’s healthcare goods. Customers are increasingly gravitating toward eco-friendly and conscientious companies, which is driving much-needed action toward sustainability. This has caused market disruption, with huge established firms losing clients to entrepreneurs that meet the sustainable criterion.